NCT00865124
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
See it on ClinicalTrials.gov ↗64 people
37.5%
62.5%
24 womenmiddle line = equal numbers40 men
- Phase
- NA
- Paid for by
- Brigham and Women's Hospital
- Finished
- 2014-05
- Health conditions
- Type 2 Diabetes Mellitus, Vascular Disease
- Who could join
- Anyone
- Ages
- 18 Years – 70 Years
- Average age
- mean 54.72 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- Not reported
Women left out
- No pregnant women
Women who were pregnant could not join.
“pregnancy,”
- No hormone therapy
Women taking menopause hormones or gender-affirming hormones could not join.
“use of cyclic hormone replacement therapy”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“renal disease not related to diabetes mellitus,”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“clinical evidence of heart disease (angina, heart failure, unstable angina),cerebrovascular or peripheral vascular disease,”
- No diabetes
Women with diabetes were turned away.
“renal disease not related to diabetes mellitus,”
- No smokers
Women who smoke or use nicotine were turned away.
“current smoker,\*”
Study titles and rules are shown in their original English.